share_log

British American Tobacco | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

英美煙草 | FWP:自由書寫募資說明書

美股SEC公告 ·  02/16 06:06

Moomoo AI 已提取核心訊息

B.A.T Capital Corporation, a subsidiary of British American Tobacco, has announced the pricing of two series of notes on February 15, 2024. The offering includes $850 million of 5.834% notes due in 2031 and $850 million of 6.000% notes due in 2034. The notes are senior and unsubordinated, with interest payments to be made semi-annually. The 2031 Notes and 2034 Notes are priced at 100.000% and 99.437% of their principal amounts, respectively, with net proceeds before expenses totaling approximately $847 million for the 2031 Notes and $842 million for the 2034 Notes. The notes are expected to settle on February 20, 2024, and have been rated Baa2 by Moody's, BBB+ by S&P, and BBB by Fitch. The offering is registered with the SEC and the notes will be listed on the New York Stock Exchange, subject to approval. Barclays Capital Inc., HSBC Securities (USA) Inc., and other financial institutions are managing the book-running.
B.A.T Capital Corporation, a subsidiary of British American Tobacco, has announced the pricing of two series of notes on February 15, 2024. The offering includes $850 million of 5.834% notes due in 2031 and $850 million of 6.000% notes due in 2034. The notes are senior and unsubordinated, with interest payments to be made semi-annually. The 2031 Notes and 2034 Notes are priced at 100.000% and 99.437% of their principal amounts, respectively, with net proceeds before expenses totaling approximately $847 million for the 2031 Notes and $842 million for the 2034 Notes. The notes are expected to settle on February 20, 2024, and have been rated Baa2 by Moody's, BBB+ by S&P, and BBB by Fitch. The offering is registered with the SEC and the notes will be listed on the New York Stock Exchange, subject to approval. Barclays Capital Inc., HSBC Securities (USA) Inc., and other financial institutions are managing the book-running.
英美菸草公司的子公司B.A.T Capital Corporation已於2024年2月15日宣佈了兩系列票據的定價。此次發行包括2031年到期的8.5億美元5.834%的票據和2034年到期的8.5億美元6.000%的票據。這些票據是優先票據且無次級票據,利息將每半年支付一次。2031年票據和2034年票據的定價分別爲其本金的100.000%和99.437%,2031年票據的扣除支出前淨收益總額約爲8.47億美元,2034年票據的扣除支出前淨收益總額約爲8.47億美元。這些票據預計將於2024年2月20日結算,並被穆迪評爲Baa2,被標準普爾評爲BBB+,被惠譽評爲BBB。此次發行已在美國證券交易委員會註冊,票據將在紐約證券交易所上市,但需獲得批准。巴克萊資本公司、匯豐證券(美國)公司和其他金融機構正在管理賬面業務。
英美菸草公司的子公司B.A.T Capital Corporation已於2024年2月15日宣佈了兩系列票據的定價。此次發行包括2031年到期的8.5億美元5.834%的票據和2034年到期的8.5億美元6.000%的票據。這些票據是優先票據且無次級票據,利息將每半年支付一次。2031年票據和2034年票據的定價分別爲其本金的100.000%和99.437%,2031年票據的扣除支出前淨收益總額約爲8.47億美元,2034年票據的扣除支出前淨收益總額約爲8.47億美元。這些票據預計將於2024年2月20日結算,並被穆迪評爲Baa2,被標準普爾評爲BBB+,被惠譽評爲BBB。此次發行已在美國證券交易委員會註冊,票據將在紐約證券交易所上市,但需獲得批准。巴克萊資本公司、匯豐證券(美國)公司和其他金融機構正在管理賬面業務。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息